All Stories

  1. Immunogenicity and safety of heterologous boost immunization with PastoCovac Plus against COVID-19 in ChAdOx1-S or BBIBP-CorV primed individuals

    Article • PLoS Pathogens, November 2023, PLOS

    Dr Amitis Ramezani

  2. Production of Recombinant HIV-1 p24-Nef Protein in Two Forms as Potential Candidate Vaccines in Three Vehicles

    Article • Current Drug Delivery, July 2020, Bentham Science Publishers

    Dr Amitis Ramezani

  3. Seroprevalence, molecular epidemiology and quantitation of parvovirus B19 DNA levels in Iranian blood donors

    Article • Journal of Medical Virology, May 2018, Wiley

    Dr Amitis Ramezani, Maryam Zadsar, Arezoo Aghakhani

  4. Preventive Human Papillomavirus (HPV) Vaccines: Immunogenicity, Efficacy and Safety

    Article • January 2018, Bentham Science Publishers

    Arezoo Aghakhani, Dr Amitis Ramezani

  5. Occult hepatitis B virus infection and S gene escape mutants in HIV-infected patients after hepatitis B virus vaccination

    Article • International Journal of STD & AIDS, July 2016, SAGE Publications

    Dr Amitis Ramezani, Arezoo Aghakhani

  6. Significance of hepatitis E virus infection in HIV-infected patients: a challenging issue

    Article • Asian Pacific Journal of Tropical Disease, May 2015, Elsevier

    Dr Amitis Ramezani, Arezoo Aghakhani

  7. Frequency and genotype of human parvovirus B19 among Iranian patients infected with HIV

    Article • Journal of Medical Virology, March 2015, Wiley

    Dr Amitis Ramezani, Arezoo Aghakhani

  8. Prevalence of BK viremia in Iranian hemodialysis and peritoneal dialysis patients

    Article • Infectious Diseases, March 2015, Taylor & Francis

    Dr Amitis Ramezani, Arezoo Aghakhani

  9. Comparison of two durations of triple-drug therapy in patients with uncomplicated brucellosis: A randomized controlled trial

    Article • Scandinavian Journal of Infectious Diseases, June 2014, Taylor & Francis

    Dr Amitis Ramezani, Arezoo Aghakhani

  10. HCV, HBV, and HIV seroprevalence, coinfections, and related behaviors among male injection drug users in Arak, Iran

    Article • AIDS Care, February 2014, Taylor & Francis

    Dr Amitis Ramezani, Arezoo Aghakhani

  11. Serological response to one intradermal or intramuscular hepatitis B virus vaccine booster dose in human immunodeficiency virus-infected nonresponders to standard vaccination

    Article • Perspectives in Clinical Research, January 2014, Medknow

    Dr Amitis Ramezani, Arezoo Aghakhani

  12. Importance of Isolated Anti-HBc in Detection of Occult Hepatitis B Virus Infection in Hemodialysis Patients

    Article • Therapeutic Apheresis and Dialysis, September 2013, Wiley

    Dr Amitis Ramezani, Arezoo Aghakhani

  13. No Correlation Between Interleukin-10 Gene Promoter Polymorphisms and Hepatitis B Virus Infection Outcome

    Article • Hepatitis Monthly, May 2013, Kowsar Medical Institute

    Dr Amitis Ramezani, Arezoo Aghakhani

  14. Frequency and Genotype of Hepatitis D Virus Infection in Patients Infected with HIV and Those Undergoing Hemodialysis

    Article • Hepatitis Monthly, May 2013, Kowsar Medical Institute

    Dr Amitis Ramezani, Arezoo Aghakhani

  15. Serum Profile of T Helper 1 and T Helper 2 Cytokines in Hepatitis C Virus Infected Patients

    Article • Hepatitis Monthly, December 2012, Kowsar Medical Institute

    Dr Amitis Ramezani, Arezoo Aghakhani

  16. Viral Hepatitis and HIV Infection Among Injection Drug Users in a Central Iranian City

    Article • Journal of Addiction Medicine, December 2012, Wolters Kluwer Health

    Dr Amitis Ramezani, Arezoo Aghakhani

  17. Occult hepatitis B infection in different high risk patients

    Article • Hepatitis Monthly, July 2012, Kowsar Medical Institute

    Dr Amitis Ramezani, Arezoo Aghakhani

  18. Viral Hepatitis and HIV Infection in Hemodialysis Patients

    Article • Hepatitis Monthly, July 2012, Kowsar Medical Institute

    Dr Amitis Ramezani, Arezoo Aghakhani

  19. Occult Hepatitis B Virus Infection in Hemodialysis Patients: A Concept for Consideration

    Article • Therapeutic Apheresis and Dialysis, May 2012, Wiley

    Dr Amitis Ramezani, Arezoo Aghakhani, Amitis Ramezani

  20. The Influence of Human Leukocyte Antigen and IL-10 Gene Polymorphisms on Hepatitis B Virus Outcome

    Article • Hepatitis Monthly, May 2012, Kowsar Medical Institute

    Dr Amitis Ramezani, Arezoo Aghakhani

  21. Persistence of antibody to hepatitis B surface antigen among vaccinated children in a low hepatitis B virus endemic area

    Article • World Journal of Pediatrics, August 2011, Springer Science + Business Media

    Dr Amitis Ramezani, Arezoo Aghakhani

  22. Reply to Letter to the Editor: Occult Hepatitis B Virus Infection in Hemodialysis Patients With Isolated Hepatitis B Core Antibody: A Multicenter Study

    Article • Therapeutic Apheresis and Dialysis, November 2010, Wiley

    Dr Amitis Ramezani, Arezoo Aghakhani

  23. Serological pattern of anti-HBc alone infers occult hepatitis B virus infection in high-risk individuals in Iran

    Article • The Journal of Infection in Developing Countries, October 2010, Journal of Infection in Developing Countries

    Dr Amitis Ramezani, Arezoo Aghakhani

  24. Occult HBV infection

    Article • Microbiologia Medica, September 2010, PAGEPress Publications

    Dr Amitis Ramezani

  25. The role of human papillomavirus infection in prostate carcinoma

    Article • Scandinavian Journal of Infectious Diseases, July 2010, Taylor & Francis

    Dr Amitis Ramezani, Arezoo Aghakhani

  26. Assessing subtype and drug-resistance-associated mutations among antiretroviral-treated HIV-infected patients

    Article • AIDS, July 2010, Wolters Kluwer Health

    Dr Amitis Ramezani, Arezoo Aghakhani

  27. Seroepidemiology of hepatitis A virus in children of different age groups in Tehran, Iran: Implications for health policy

    Article • Travel Medicine and Infectious Disease, May 2010, Elsevier

    Dr Amitis Ramezani, Arezoo Aghakhani

  28. Surface gene mutations of hepatitis B virus among high-risk patients with occult hepatitis B virus infection

    Article • Diagnostic Microbiology and Infectious Disease, March 2010, Elsevier

    Dr Amitis Ramezani, Arezoo Aghakhani

  29. Occult Hepatitis B Virus Infection in Hemodialysis Patients With Isolated Hepatitis B Core Antibody: A Multicenter Study

    Article • Therapeutic Apheresis and Dialysis, January 2010, Wiley

    Dr Amitis Ramezani, Arezoo Aghakhani

  30. Hepatitis B virus genotype in Iranian patients with hepatocellular carcinoma

    Article • International Journal of Infectious Diseases, November 2009, Elsevier

    Dr Amitis Ramezani, Arezoo Aghakhani

  31. Comparison of QuantiFERON TB-G-test to TST for detecting latent tuberculosis infection in a high-incidence area containing BCG-vaccinated population

    Article • Journal of Evaluation in Clinical Practice, February 2009, Wiley

    Dr Amitis Ramezani, Arezoo Aghakhani

  32. Frequency and genotype of GB virus C among Iranian patients infected with HIV

    Article • Journal of Medical Virology, November 2008, Wiley

    Dr Amitis Ramezani, Arezoo Aghakhani

  33. Association of human leukocyte antigen polymorphism with outcomes of hepatitis B virus infection

    Article • Journal of Gastroenterology and Hepatology, November 2008, Wiley

    Dr Amitis Ramezani, Arezoo Aghakhani

  34. Frequency and associated factors of proteinuria in Iranian HIV-positive patients

    Article • International Journal of Infectious Diseases, September 2008, Elsevier

    Dr Amitis Ramezani, Arezoo Aghakhani

  35. Reply to the Letter to the Editor

    Article • International Journal of Infectious Diseases, July 2008, Elsevier

    Dr Amitis Ramezani

  36. Rate of YMDD motif mutants in lamivudine-untreated Iranian patients with chronic hepatitis B virus infection

    Article • International Journal of Infectious Diseases, May 2008, Elsevier

    Dr Amitis Ramezani, Arezoo Aghakhani

  37. Persistence of Hepatitis B Vaccine Immunity in Hemodialysis Patients

    Article • Therapeutic Apheresis and Dialysis, April 2008, Wiley

    Dr Amitis Ramezani, Arezoo Aghakhani

  38. Risk factors for human brucellosis in Iran: a case–control study

    Article • International Journal of Infectious Diseases, March 2008, Elsevier

    Dr Amitis Ramezani, Arezoo Aghakhani

  39. Occult Hepatitis B Virus Infection in HIV-Infected Patients with Isolated Hepatitis B Core Antibody

    Article • Intervirology, January 2008, Karger Publishers

    Dr Amitis Ramezani, Arezoo Aghakhani

  40. Detection of hepatitis G virus envelope protein E2 antibody in blood donors

    Article • International Journal of Infectious Diseases, January 2008, Elsevier

    Dr Amitis Ramezani, Dr Vahid Salimi

  41. Hepatitis G Virus Exposure in Dialysis Staff

    Article • Therapeutic Apheresis and Dialysis, October 2007, Wiley

    Dr Amitis Ramezani, Arezoo Aghakhani

  42. Hepatitis G virus exposure in dialysis patients

    Article • International Urology and Nephrology, September 2007, Springer Science + Business Media

    Dr Amitis Ramezani, Arezoo Aghakhani

  43. Frequency of human papillomavirus infection in oesophageal squamous cell carcinoma in Iranian patients

    Article • Scandinavian Journal of Infectious Diseases, January 2007, Taylor & Francis

    Dr Amitis Ramezani, Arezoo Aghakhani